Cormorant Asset Management, LP Igm Biosciences, Inc. Transaction History

Cormorant Asset Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $5.34 Million - $10.3 Million	-402,200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $1.31 Million - $2.91 Million	-97,800 Reduced 19.56%	402,200 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $4.14 Million - $9.96 Million	150,000 Added 42.86%	500,000 $14.7 Million
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $6.58 Million - $9.07 Million	100,000 Added 40.0%	350,000 $23 Million
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $14.2 Million - $23.7 Million	-245,769 Reduced 49.57%	250,000 $20.8 Million

Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $7.46 Million - $12.6 Million	-104,231 Reduced 17.37%	495,769 $38 Million
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $17.8 Million - $43.1 Million	375,000 Added 166.67%	600,000 $53 Million
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $4.95 Million - $9.67 Million	-115,146 Reduced 33.85%	225,000 $16.6 Million
Q2 2020 Aug 14, 2020	SELL	$51.3 - $75.21 $4.41 Million - $6.46 Million	-85,958 Reduced 20.17%	340,146 $24.8 Million
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $8.5 Million - $19.9 Million	269,704 Added 172.45%	426,104 $23.9 Million
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $2.78 Million - $3.8 Million	156,400 New	156,400 $2.78 Million

20.5M

11.1K

5.1K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $199M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.